Report cover image

Renal Biomarkers Market, By Biomarker Type (Functional Biomarker (Serum Creatinine, Serum Cystatin C, Urine Albumin), Up-Regulated Proteins (Neutrophil gelatinase-associated lipocalin, Kidney injury molecule 1, Interleukin 18), Others), By Technique (Enzy

Publisher Coherent Market Insights
Published May 29, 2022
Length 164 Pages
SKU # CMI17212070

Description

Renal Biomarkers Market, By Biomarker Type (Functional Biomarker (Serum Creatinine, Serum Cystatin C, Urine Albumin), Up-Regulated Proteins (Neutrophil gelatinase-associated lipocalin, Kidney injury molecule 1, Interleukin 18), Others), By Technique (Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay, Liquid Chromatography-Mass Spectrometry), By End User (Diagnostic Labs, Outpatient Clinics, Research Centers, Hospitals), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Chronic kidney disease (CKD) involves gradual loss of functioning of kidneys. The normal function of kidneys are to filter out and excrete wastes, and excess fluids from the blood are excreted through urine. However, when an individual is suffering from chronic kidney disease, kidneys cannot perform their natural function and wastes, fluids, and electrolytes build up in the body in excess amounts. Signs and symptoms of chronic kidney disease are not apparent until kidney function becomes significantly impaired. For this purpose various diagnostic tests are performed which involve use of various tests which asses biomarkers to understand functioning of the kidneys. Increase or decrease in values of these biomarkers indicates dysfunction of kidneys.
Restraints of the Global Renal Biomarkers Market
Factors such as low sensitivity and specificity of biomarkers is expected to hinder growth of the global renal biomarkers market. For instance, some renal biomarkers such as L-18 are more specific although are not very sensitive, while other biomarkers such as osteopontin are highly sensitive though they are not specific.
Key features of the study:
This report provides in-depth analysis of the global renal biomarkers market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global renal biomarkers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Beckman Coulter, Inc., (Danaher Corporation), Thermo Fisher Scientific Inc., Abbott Laboratories, BIOPORTO A/S, Astute Medical, Inc., Randox Laboratories Ltd., and SphingoTec GmbH.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global renal biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Renal Biomarkers Market, By Biomarker Type:
Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-Regulated Proteins
Neutrophil gelatinase-associated lipocalin
Kidney injury molecule 1
Interleukin 18
Others
Global Renal Biomarkers Market, By Technique:
Enzyme Linked Immunosorbent Assay
Particle-Enhanced Turbidimetric Immunoassay
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay
Liquid Chromatography-Mass Spectrometry
Global Renal Biomarkers Market, By End User:
Diagnostic Labs
Outpatient Clinics
Research Centers
Hospitals
Global Renal Biomarkers Market, By Geography:
North America
By Biomarker Type
Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-Regulated Proteins
Neutrophil gelatinase-associated lipocalin
Kidney injury molecule 1
Interleukin 18
Others
By Technique
Enzyme Linked Immunosorbent Assay
Particle-Enhanced Turbidimetric Immunoassay
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay
Liquid Chromatography-Mass Spectrometry
By End User
Diagnostic Labs
Outpatient Clinics
Research Centers
Hospitals
By Country:
U.S.
Canada
Europe
By Biomarker Type
Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-Regulated Proteins
Neutrophil gelatinase-associated lipocalin
Kidney injury molecule 1
Interleukin 18
Others
By Technique
Enzyme Linked Immunosorbent Assay
Particle-Enhanced Turbidimetric Immunoassay
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay
Liquid Chromatography-Mass Spectrometry
By End User
Diagnostic Labs
Outpatient Clinics
Research Centers
Hospitals
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Biomarker Type
Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-Regulated Proteins
Neutrophil gelatinase-associated lipocalin
Kidney injury molecule 1
Interleukin 18
Others
By Technique
Enzyme Linked Immunosorbent Assay
Particle-Enhanced Turbidimetric Immunoassay
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay
Liquid Chromatography-Mass Spectrometry
By End User
Diagnostic Labs
Outpatient Clinics
Research Centers
Hospitals
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Biomarker Type
Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-Regulated Proteins
Neutrophil gelatinase-associated lipocalin
Kidney injury molecule 1
Interleukin 18
Others
By Technique
Enzyme Linked Immunosorbent Assay
Particle-Enhanced Turbidimetric Immunoassay
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay
Liquid Chromatography-Mass Spectrometry
By End User
Diagnostic Labs
Outpatient Clinics
Research Centers
Hospitals
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Biomarker Type
Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-Regulated Proteins
Neutrophil gelatinase-associated lipocalin
Kidney injury molecule 1
Interleukin 18
Others
By Technique
Enzyme Linked Immunosorbent Assay
Particle-Enhanced Turbidimetric Immunoassay
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay
Liquid Chromatography-Mass Spectrometry
By End User
Diagnostic Labs
Outpatient Clinics
Research Centers
Hospitals
By Country:
GCC
Israel
Rest of Middle East
Africa
By Biomarker Type
Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-Regulated Proteins
Neutrophil gelatinase-associated lipocalin
Kidney injury molecule 1
Interleukin 18
Others
By Technique
Enzyme Linked Immunosorbent Assay
Particle-Enhanced Turbidimetric Immunoassay
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay
Liquid Chromatography-Mass Spectrometry
By End User
Diagnostic Labs
Outpatient Clinics
Research Centers
Hospitals
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Beckman Coulter, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Thermo Fisher Scientific Inc.
Abbott Laboratories
BIOPORTO A/S
Astute Medical, Inc.
Randox Laboratories Ltd.
SphingoTec GmbH
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

164 Pages
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Biomarker Type
Market Snippet, By Technique
Market Snippet, By End User
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Regulatory Scenario
PEST Analysis
4. Global Renal Biomarkers Market, By Biomarker Type, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Functional Biomarker
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-Regulated Proteins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Neutrophil gelatinase-associated lipocalin
Kidney injury molecule 1
Interleukin 18
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
5. Global Renal Biomarkers Market, By Technique, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Enzyme Linked Immunosorbent Assay
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Particle-Enhanced Turbidimetric Immunoassay
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Colorimetric Assay
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Chemiluminescent Enzyme Immunoassay
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Liquid Chromatography-Mass Spectrometry
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. Global Renal Biomarkers Market, By End User, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Diagnostic Labs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Outpatient Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Research Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. Global Renal Biomarkers Market, By Regions, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Company Profiles
Beckman Coulter, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Thermo Fisher Scientific Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Abbott Laboratories
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
BIOPORTO A/S
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Astute Medical, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Randox Laboratories Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
SphingoTec GmbH
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 32 market data tables and 21 figures on “Renal Biomarkers Market – Global forecast to 2028.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us